Scarica l'app Stockscreener
66.25
0.56%
0.37
Dopo l'orario di chiusura:
66.20
-0.05
-0.08%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Perché AZN Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Astrazeneca PLC Borsa (AZN) Ultime notizie
Better Buy: Novo Nordisk vs. AstraZeneca - Yahoo Finance
ASTRAZENECA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against AstraZeneca P - PR Newswire
AZN INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Business Wire
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages AstraZeneca PLC Investors to Secure - The Bakersfield Californian
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AZN - GlobeNewswire Inc.
AstraZeneca PLC Investors: Please contact the Portnoy Law - GlobeNewswire
AstraZeneca PLC ADR rises Friday, still underperforms market - MarketWatch
AZN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that AstraZeneca PLC Investors Have Opportunity to Lead Class Action Lawsuit! - AccessWire
Lowey Dannenberg Notifies AstraZeneca PLC (“AstraZeneca” or - GlobeNewswire
AstraZeneca outperforms market despite losses on the day - MarketWatch
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AZN - AccessWire
AstraZeneca PLC ADR rises Thursday, outperforms market - MarketWatch
AZN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that AstraZeneca PLC Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire
AstraZeneca call volume above normal and directionally bullish - TipRanks
AstraZeneca PLC Class Action: The Gross Law Firm Reminds AstraZe - GuruFocus.com
AstraZeneca rises Thursday, outperforms market - MarketWatch
AstraZeneca PLC Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsAZN - GuruFocus.com
AstraZeneca Announces Share Capital and Voting Rights Update - TipRanks
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AstraZeneca PLC. of Class Action Lawsuit and Upcoming DeadlinesAZN - PR Newswire
Zacks Research Boosts Earnings Estimates for AstraZeneca - MarketBeat
AZN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that AstraZeneca PLC Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire
AstraZeneca PLC ADR falls Tuesday, still outperforms market - MarketWatch
AZN Investors have Opportunity to Lead AstraZeneca PLC Securities Fraud lawsuit - The Eastern Progress Online
AstraZeneca rises Tuesday, still underperforms market - MarketWatch
DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors - GlobeNewswire
AZN Investors Have Opportunity to Lead AstraZeneca PLC Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
AstraZeneca PLC ADR outperforms market despite losses on the day - MarketWatch
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca - PR Newswire
Shareholders that lost money on AstraZeneca PLC (AZN) Urged - GlobeNewswire
AstraZeneca falls Monday, underperforms market - MarketWatch
Class Action Filed Against AstraZeneca PLC (AZN)February 21, 2025 Deadline to JoinContact The Gross Law Firm - GuruFocus.com
Is AstraZeneca PLC (AZN) Among the U.K. Dividend Champions for 2024? - Yahoo Finance
AZN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire
Is AstraZeneca PLC (AZN) Among the U.K. Dividend Aristocrats for 2024? - Yahoo Finance
AstraZeneca - Britannica
AstraZeneca PLC (NASDAQ:AZN) Short Interest Up 35.9% in December - MarketBeat
Astrazeneca (AZN) Stock Moves -0.39%: What You Should Know - Yahoo Finance
AstraZeneca PLC ADR falls Friday, still outperforms market - MarketWatch
AZN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Business Wire
ROSEN, A TOP-RANKED LAW FIRM, Encourages AstraZeneca PLC - GlobeNewswire
AZN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that AstraZeneca PLC Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire
Here's Why Astrazeneca (AZN) is a Strong Value Stock - Yahoo Finance
AstraZeneca PLC (NASDAQ:AZN) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Syncona investment sells cancer study assets to AstraZeneca for $12m - ShareCast
AZN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that AstraZeneca PLC Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire
AstraZeneca withdraws EU application for lung cancer drug By Investing.com - Investing.com Australia
AstraZeneca PLC ADR outperforms market on strong trading day - MarketWatch
ASTRAZENECA SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against AstraZeneca PLCAZN - Business Wire
AstraZeneca withdraws EU application for lung cancer drug - Investing.com
AZN, Daiichi Withdraw EU Filing for Dato-DXd in Nonsquamous NSCLC - Yahoo Finance
AZN INVESTOR DEADLINE: AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
AstraZeneca's (LON:AZN) investors will be pleased with their respectable 55% return over the last five years - Yahoo Finance
Achilles Therapeutics sells technology assets to AstraZeneca for $12M - Yahoo Finance
AstraZeneca, Daiichi Sankyo have voluntarily withdrawn a Dato-DXd MAA in EU - Yahoo Finance
Here's Why AstraZeneca (LON:AZN) Can Manage Its Debt Responsibly - Simply Wall St
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel - The Bakersfield Californian
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages AstraZeneca - GlobeNewswire
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):